Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Combination SGLT2, GLP-1 therapy lowers risk for adverse CV outcomes in type 2 diabetes Healio 28 days ago
2 The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study DocWire News 3 days ago
3 Video: SGLT2 inhibitors 'gaining momentum' in heart failure treatment Healio 17 days ago
4 SGLT2 Inhibitors and Gout Prevention Diabetes In Control 12 days ago
5 SGLT2 Inhibitor Safe for Kidneys in Hospitalized COVID Patients Medpage Today 17 days ago
6 Rajeev Raghavan, MD: SGLT2 Inhibitors and GLP-1 Receptor Agonists MD Magazine 8 days ago
7 SGLT2 inhibitors tied to double the risk of genital infections Australian Doctor 7 days ago
8 SGLT2 Inhibitors Reduce Hyperkalemia in High-Risk T2DM Patients Medical Dialogues 14 days ago
9 Daily Medication Pearl: Ertugliflozin (Steglatro) Pharmacy Times 14 days ago
10 Keeping SCORED: How Sotagliflozin May Be the Rising Star of SGLT Inhibitors DocWire News 26 days ago
11 Spherix Uncovers Key Differences in the Management of Chronic Kidney Disease Patients in Europe Versus the US PR Newswire 21 days ago
12 SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk Renal and Urology News 2 months ago
13 Use of Newer Type 2 Diabetes Drugs Gives Hope but Costs a Concern Medscape 7 days ago
14 Dapagliflozin Meets Primary End Point in Phase 3 Trial, Reduces Risk of Cardiovascular Death and Worsening Heart Failure Managed Markets Network 11 days ago
15 Key Points From the New Heart Failure Guidelines Medscape 12 days ago
16 SGLT2 Inhibitors for Acute Heart Failure Decrease Risk for Rehospitalization The Cardiology Advisor 3 months ago
17 Direct cardiac effects of SGLT2 inhibitors Cardiovascular Diabetology 2 months ago
18 Study shows early benefits of SGLT2 inhibitors in patients with heart failure Healio 1 month ago
19 Focus on HFpEF and potential therapies MD Linx 5 days ago
20 SGLT2 Inhibitors Show Success Against HFpEF in New UK Study Managed Markets Network 6 months ago
21 Dr Deepak Bhatt on the Importance of In-Hospital Initiation of SGLT2 Inhibitors Managed Markets Network 8 months ago
22 FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes Healio 3 days ago
23 Farxiga (Dapagliflozin) Oral: Uses, Side Effects, Dosages, Interactions 5 days ago
24 Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis Cardiovascular Diabetology 3 months ago
25 Combination Therapy with Metformin and an SGLT2 Inhibitor Diabetes In Control 4 months ago
26 Reduction in Atrial Arrhythmias in Patients With CIED on SGLT2 inhibitors Physician's Weekly 5 months ago
27 SGLT2 Inhibitors Underprescribed for Chronic Kidney Disease Renal and Urology News 4 months ago
28 SGLT2 inhibitors reduced gout incidence by 11% in patients with type 2 diabetes Healio 5 months ago
29 SGLT2 Inhibitors in Primary Care: 'All Hands on Deck' for Improving Heart Failure Outcomes Medscape 5 months ago
30 SGLT2 Inhibitors May Cut Repeat Syncope in Type 2 Diabetes Medscape 3 months ago
31 Encourage Further SGLT2 Inhibitor Treatment for Diabetes, Kidney Disease, Expert Says Managed Markets Network 8 months ago
32 SGLT2 Inhibitors Associated With High Hemoglobin Level, Low Prevalence of Anemia MD Magazine 6 months ago
33 SGLT2 in Patients With Type 2 Diabetes Lowers Risk of Gout Medscape 3 months ago
34 Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis Cardiovascular Diabetology 2 months ago
35 SGLT2 Inhibitors Improve Cardiovascular Outcomes Across Groups Medscape 4 months ago
36 Diabetes Drugs Market to See Major Growth by 2028 | Novartis, Taloph, Sanofi Digital Journal 5 days ago
37 Bayer's Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chief FiercePharma 6 months ago
38 Cost-effectiveness of Intensification With SGLT2 Inhibitors for Type 2 Diabetes Managed Markets Network 9 months ago
39 VIDEO: Benefits from SGLT2 inhibitors 'cover the whole continuum of heart failure care' Healio 4 months ago
40 Optimal Use of SGLT2 Inhibitors and GLP-1 Agonists: 5 Things to Know Medscape 7 months ago
41 Finerenone plus SGLT2 inhibition may yield additive CV, kidney benefits: FIGARO-DKD Healio 7 months ago
42 Structural basis of inhibition of the human SGLT2–MAP17 glucose transporter 5 months ago
43 ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals FiercePharma 1 month ago
44 SGLT2 Inhibitor Eases Symptoms for HFpEF Patients Medpage Today 8 months ago
45 Type 2 Diabetes: SGLT2 Inhibitors and GLP-1 Receptor Agonists MD Magazine 6 months ago
46 Algorithm Predicts Response to SGLT2, DPP-4 Inhibitors in Diabetes Medscape 6 months ago
47 NICE recommends wider offering of dual metformin and SGLT2 inhibitor treatment in type 2 diabetes patients The Pharmaceutical Journal 3 months ago
48 Dr Ian Neeland Describes Physiologic Effects of SGLT2 Inhibitors on Sleep Apnea Managed Markets Network 6 months ago
49 Special Podcast Sglt2 Inhibitors and Diabetic Kidney Disease | Journals Gateway Diabetes Journal 8 months ago
50 Investigational Liver Drug Also Effective in Patients With Hypothyroidism Medpage Today 16 hours ago
51 Primary care intervention increases prescriptions for SGLT2 inhibitors, GLP-1 agonists Healio 1 month ago
52 In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? Medpage Today 2 months ago
53 Another SGLT2 Inhibitor OK'd for Heart Failure Medpage Today 9 months ago
54 Ildong releases antidiabetic DPP4+SGLT2 combo drug Qtern KBR 7 months ago
55 Study: SGLT2 Inhibitors Promote Weight Loss More Than GLP-1 Receptor Agonists Pharmacy Times 7 months ago
56 Clinical Pearl of the Day: SGLT2 Inhibitors and Glomerular Filtration Rate Cutoffs Pharmacy Times 10 months ago
57 Review: SGLT2 Inhibitors Hold Promise in Improving Renal Outcomes Managed Markets Network 10 months ago
58 SGLT2 Inhibitors Reduce Cardiovascular Deaths, Despite Diabetes Drug Topics 14 days ago
59 EASD 2021: SGLT2 inhibitors improve efficacy in quadruple combination therapy Pharmaceutical Technology 7 months ago
60 Dr Rudolf de Boer on SGLT2 Inhibitor Success Across Disease States Managed Markets Network 8 months ago
61 Study: Patients With Type 2 Diabetes Prescribed SGLT2 Inhibitors Lose More Weight Than Those Prescribed GLP-1 Receptor Agonists Pharmacy Times 10 months ago
62 Diabetes drug from the group of SGLT2 inhibitors normalizes insulin action in the brain EurekAlert 5 months ago
63 FDA approves empagliflozin to reduce CV death, HF hospitalization in HFpEF Healio 3 months ago
64 Anti-arrhythmic effects of SGLT2 inhibitors 'may be an alias for improving heart failure' Healio 8 months ago
65 GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Healio 4 months ago
66 SGLT2 inhibitors for diabetes Medical News Today 1 year ago
67 No Increase in Fracture Risk from SGLT2 Inhibitor Use, Study Finds Endocrinology Network 7 months ago
68 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT TCTMD 9 months ago
69 Beyond Diabetes: SGLT2 Inhibitors in Heart Failure, CKD, and in Combination With GLP-1 RAs Managed Markets Network 11 months ago
70 Multisystem Impact of SGLT2 Inhibitors in Cardiorenal Metabolic Syndrome Managed Markets Network 9 months ago
71 J&J looks to toss its SGLT2 hat in the ring for two types of heart failure Endpoints News 6 months ago
72 SGLT2 inhibitors now 'pillars of care' for HF Healio 1 year ago
73 FDA Moves Generic Dapagliflozin a Step Closer to US Sales Medscape 3 months ago
74 SGLT2 Inhibitors Changed the Treatment Paradigm for T2D, Have Implications for Managed Care Managed Markets Network 1 year ago
75 SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease, New Spherix Data Reveals PR Newswire 2 months ago
76 Should SGLT2 inhibitors be first-line therapy for type 2 diabetes? Healio 12 months ago
77 Results From FIGARO-DKD and FIDELITY: Finerenone + SGLT2 Inhibitors Managed Markets Network 8 months ago
78 Study Outlines Risk of DKA in Patients Taking SGLT2 Inhibitors Managed Markets Network 2 years ago
79 EMPEROR-Preserved, and the “Very Elegant” SGLT2 Inhibitors, to Highlight ESC Congress Managed Markets Network 9 months ago
80 Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits Medpage Today 10 months ago
81 Comparative Rates of Diabetic Ketoacidosis in T2D According to Drug Class Endocrinology Advisor 2 months ago
82 Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials AHA Journals 1 month ago
83 SGLT2 Inhibitors Shine as Therapy for Patients With Heart Failure Managed Markets Network 2 years ago
84 New Data Presented for Finerenone, Vericiguat, and SGLT2 Inhibitors at HF Session Managed Markets Network 6 months ago
85 Jardiance becomes first SGLT2 inhibitor to show benefit in HFpEF PharmaTimes 10 months ago
86 SGLT2 Inhibitor Use in Chronic Kidney Disease Managed Markets Network 6 months ago
87 SGLT2 Inhibitors: What It Is, Drugs, Side Effects, and More WebMD 4 months ago
88 SGLT2 Inhibitors for T1D? Experts Debate at ENDO 2021 Medscape 1 year ago
89 SGLT2 Inhibitors: Types, Side Effects, and More Healthline 3 years ago
90 First case of infection from diabetes medication in India The Hindu 1 month ago
91 Outrage Over Dapagliflozin Withdrawal for Type 1 Diabetes in EU Medscape 5 months ago
92 Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease | Eli Lilly and Company Eli Lilly 2 months ago
93 SGLT2 Inhibitors for Type 2 Diabetes How to Talk To Your Doctor About Them 3 years ago
94 SGLT2 inhibitors superior to GLP-1 receptor agonists for some CV outcomes Healio 8 months ago
95 SCORED, SOLOIST Trials to Add to Evidence for Treating Diabetes with SGLT2 Inhibitors Pharmacy Times 1 year ago
96 Most Eligible Patients With Diabetic Kidney Disease Not Receiving SGLT2 Inhibitor Prescriptions Managed Markets Network 12 months ago
97 SGLT2 Inhibitors, GLP-1 RAs Featured in Prevention Guidelines Managed Markets Network 7 months ago
98 Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes GlobeNewswire 7 months ago
99 Finerenone and SGLT2 Inhibitors Could Have Additive Effect on Kidney Protection Endocrinology Network 11 months ago
100 At What Price Will Newer Anti-Diabetes Drugs Be Cost Effective? Medscape 6 months ago